Switch theme
Sign up to access all valuation multiples
IHH Healthcare Bhd operates a network of healthcare clinics, hospitals, and postoperative rehabilitation centers. It also provides ancillary services, which include diagnostic laboratories, imaging centers, ambulatory care, and medical education facilities. The firm receives a majority proportion of its revenue through its Parkway Pantai segment, which operates hospitals and provides healthcare services in Asia. Two of Parkway Pantai's key markets are Singapore and Malaysia. The second majority proportion of revenue comes from Acibadem Holdings, a hospital operator and service provider in Central and Eastern Europe, the Middle East, and North Africa. The Group’s operating segments comprise Singapore, Malaysia, India, Greater China, Turkiye and Europe, IMU Health, and PLife REIT.
1974
70K+
LTM Revenue $5.6B
LTM EBITDA $1.3B
$16.5B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
IHH Healthcare has a last 12-month revenue of $5.6B and a last 12-month EBITDA of $1.3B.
In the most recent fiscal year, IHH Healthcare achieved revenue of $5.5B and an EBITDA of $1.4B.
IHH Healthcare expects next 12-month revenue of XXX and NTM EBITDA of XXX
See IHH Healthcare valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $4.7B | $5.5B | XXX | XXX | XXX |
| Gross Profit | $2.8B | $3.3B | XXX | XXX | XXX |
| Gross Margin | 60% | 60% | XXX | XXX | XXX |
| EBITDA | $1.4B | $1.4B | XXX | XXX | XXX |
| EBITDA Margin | 30% | 26% | XXX | XXX | XXX |
| Net Profit | $349M | $666M | XXX | XXX | XXX |
| Net Margin | 7% | 12% | XXX | XXX | XXX |
| Net Debt | $1.7B | $1.4B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 25, 2025, IHH Healthcare's stock price is MYR 7 (or $2).
IHH Healthcare has current market cap of MYR 60.7B (or $13.7B), and EV of MYR 73.1B (or $16.5B).
See IHH Healthcare trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $16.5B | $13.7B | XXX | XXX | XXX | XXX | $0.05 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 25, 2025, IHH Healthcare has market cap of $13.7B and EV of $16.5B.
IHH Healthcare's trades at 2.9x LTM EV/Revenue multiple, and 13.1x LTM EBITDA.
Analysts estimate IHH Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for IHH Healthcare and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $16.5B | XXX | XXX | XXX |
| EV/Revenue | 3.0x | XXX | XXX | XXX |
| EV/EBITDA | 11.7x | XXX | XXX | XXX |
| P/E | 22.8x | XXX | XXX | XXX |
| P/E/Growth | -3.2x | XXX | XXX | XXX |
| EV/FCF | 69.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpIHH Healthcare's NTM/LTM revenue growth is 8%
IHH Healthcare's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $44K for the same period.
Over next 12 months, IHH Healthcare's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate IHH Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for IHH Healthcare and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 16% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 26% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 0% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 34% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $44K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 56% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
IHH Healthcare acquired XXX companies to date.
Last acquisition by IHH Healthcare was XXXXXXXX, XXXXX XXXXX XXXXXX . IHH Healthcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was IHH Healthcare founded? | IHH Healthcare was founded in 1974. |
| Where is IHH Healthcare headquartered? | IHH Healthcare is headquartered in Malaysia. |
| How many employees does IHH Healthcare have? | As of today, IHH Healthcare has 70K+ employees. |
| Is IHH Healthcare publicy listed? | Yes, IHH Healthcare is a public company listed on KLS. |
| What is the stock symbol of IHH Healthcare? | IHH Healthcare trades under 5225 ticker. |
| When did IHH Healthcare go public? | IHH Healthcare went public in 2012. |
| Who are competitors of IHH Healthcare? | Similar companies to IHH Healthcare include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of IHH Healthcare? | IHH Healthcare's current market cap is $13.7B |
| What is the current revenue of IHH Healthcare? | IHH Healthcare's last 12-month revenue is $5.6B. |
| What is the current EBITDA of IHH Healthcare? | IHH Healthcare's last 12-month EBITDA is $1.3B. |
| What is the current EV/Revenue multiple of IHH Healthcare? | Current revenue multiple of IHH Healthcare is 2.9x. |
| What is the current EV/EBITDA multiple of IHH Healthcare? | Current EBITDA multiple of IHH Healthcare is 13.1x. |
| What is the current revenue growth of IHH Healthcare? | IHH Healthcare revenue growth between 2023 and 2024 was 16%. |
| Is IHH Healthcare profitable? | Yes, IHH Healthcare is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
